Last modified: 22 May 2019 17:07
The course will focus on small molecule drug discovery. Receptor theory and cell communication and signalling will be revised to facilitate understanding of the remainder of the course. The basis of the drug discovery process will be described and the phases of drug development discussed. A range of targets for drug discovery will be identified and how small molecule drug affect these will be described. Issues around drug regulation will be raised.
|Session||First Sub Session||Credit Points||25 credits (12.5 ECTS credits)|
This applied course will cover the latest developments in small molecule drug discovery and development. The course will progress logically through the process of identifying and characterising lead drug candidates to the point when they enter clinical trials. Much of the course will focus on the two main areas:
1) the latest screening protocols for lead identification from large compound libraries.
2) The inherent toxicity problems of synthetic, small molecule drugs. The second component of the course will cover in detail the steps taken to minimise any unwanted side effects in drugs used for therapy. Wherever possible the course will use real clinical examples to deliver its applied message effectively and clearly. The course will also include presentations from industry professionals.
Information on contact teaching time is available from the course guide.
MCQ written exam (50%); Presentation (25%); Poster (25%).
There are no assessments for this course.